
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<FONT SIZE=3 ><A HREF="#04ATA1695_4">QuickLinks</A></FONT>
<font size=3> -- Click here to rapidly navigate through this document</font>
<!-- TOC_END -->
<P ALIGN="RIGHT"><FONT SIZE=2><A
NAME="kj1695_exhibit_1.3"> </A>
<A NAME="toc_kj1695_1"> </A>
<BR></FONT><FONT SIZE=2><B>Exhibit 1.3    <BR>    </B></FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><A
NAME="kj1695_mutual_release_agreement"> </A>
<A NAME="toc_kj1695_2"> </A>
<BR></FONT><FONT SIZE=2><B>MUTUAL RELEASE AGREEMENT    <BR>    </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;THIS MUTUAL RELEASE AGREEMENT (this "</FONT><FONT SIZE=2><I>Release</I></FONT><FONT SIZE=2>"), dated as of December&nbsp;17, 2004, by and among (i)&nbsp;Life
Therapeutics Limited (f/k/a Gradipore Limited), a corporation organized under the laws of the Commonwealth of Australia (the "</FONT><FONT SIZE=2><I>Company</I></FONT><FONT SIZE=2>"), Life
Gels,&nbsp;Inc. (f/k/a Gradipore,&nbsp;Inc.), a Delaware corporation ("</FONT><FONT SIZE=2><I>LG</I></FONT><FONT SIZE=2>"), Life Therapeutics Plasma Holdings,&nbsp;Inc. (f/k/a Gradipore Plasma
Holdings,&nbsp;Inc.), a Delaware corporation ("</FONT><FONT SIZE=2><I>LTPH</I></FONT><FONT SIZE=2>"), LifeSera,&nbsp;Inc., (f/k/a Serologicals Specialty Biologics,&nbsp;Inc.), a Delaware
corporation ("</FONT><FONT SIZE=2><I>LifeSera</I></FONT><FONT SIZE=2>"), LifeSera Nevada,&nbsp;Inc. (f/k/a Serologicals Nevada,&nbsp;Inc.), a Nevada corporation
("</FONT><FONT SIZE=2><I>Nevada</I></FONT><FONT SIZE=2>"), LifeSera Business Trust (f/k/a Serologicals Business Trust), a Nevada business trust
("</FONT><FONT SIZE=2><I>LBT</I></FONT><FONT SIZE=2>"), LifeSera Investments, LLC (f/k/a Serologicals Investments, LLC), a Georgia limited liability company
("</FONT><FONT SIZE=2><I>LLC</I></FONT><FONT SIZE=2>"), LifeSera Management Partnership, LP (f/k/a Serologicals Management Partnership, LP), a Delaware limited partnership
("</FONT><FONT SIZE=2><I>LP</I></FONT><FONT SIZE=2>"), and Allegheny Biologicals,&nbsp;Inc., a Pennsylvania corporation ("</FONT><FONT SIZE=2><I>Allegheny</I></FONT><FONT SIZE=2>", and together
with the Company, LG, LTPH, LifeSera, Nevada, LBT, LLC, and LP, collectively, the "</FONT><FONT SIZE=2><I>Purchaser Parties</I></FONT><FONT SIZE=2>"), on the one hand, and (ii)&nbsp;Serologicals
Corporation, a Delaware corporation (the "</FONT><FONT SIZE=2><I>Holder Parent</I></FONT><FONT SIZE=2>"), and Serologicals Finance Company, a Delaware corporation
("</FONT><FONT SIZE=2><I>Holder</I></FONT><FONT SIZE=2>" and together with the Holder Parent, collectively, the "</FONT><FONT SIZE=2><I>Holder Parties</I></FONT><FONT SIZE=2>"), on the other hand. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><B>WITNESSETH  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, LG, the Company, Holder and the Holder Parent previously entered into that certain Stock Purchase Agreement dated as of December&nbsp;19, 2003 as
amended by that certain First Amendment to the Stock Purchase Agreement, dated as of January&nbsp;15, 2004 (the "</FONT><FONT SIZE=2><I>Stock Purchase Agreement</I></FONT><FONT SIZE=2>"), pursuant
to which LTPH purchased (the "</FONT><FONT SIZE=2><I>Acquisition</I></FONT><FONT SIZE=2>") all of the issued and outstanding shares of capital stock, $0.01 par value per share of LifeSera (the
"</FONT><FONT SIZE=2><I>Common Stock</I></FONT><FONT SIZE=2>"), from Holder; </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS,
pursuant to Section&nbsp;9.2 of the Stock Purchase Agreement, the Holder Parties, jointly and severally, agreed to indemnify, protect, and hold harmless the Purchaser
Indemnified Parties (as defined in the Stock Purchase Agreement) from and against any Purchaser Losses (as defined in the Stock Purchase Agreement); </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS,
pursuant to Section&nbsp;9.4 of the Stock Purchase Agreement, the Company and LG, jointly and severally, agreed to indemnify, protect, and hold harmless the Holder Indemnified
Parties (as defined in the Stock Purchase Agreement) from and against any Holder Losses (as defined in the Stock Purchase Agreement); </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS,
as consideration for the Common Stock, the Holder received, and currently holds, two promissory notes, the first in the amount of One Million Five Hundred Thousand Dollars (US
$1,500,000.00) (the "</FONT><FONT SIZE=2><I>Short Term Old Note</I></FONT><FONT SIZE=2>") and the second in the amount of Eleven Million Eight Hundred Three Thousand Eight Hundred Sixty-Seven Dollars
(US $11,803,867.00) (the "</FONT><FONT SIZE=2><I>Long Term Old Note</I></FONT><FONT SIZE=2>", together with the Short Term Old Note, the "</FONT><FONT SIZE=2><I>Old Notes</I></FONT><FONT SIZE=2>"); </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS,
subject to the terms and subject to the conditions of that certain Exchange Agreement, dated the date hereof (the "</FONT><FONT SIZE=2><I>Exchange
Agreement</I></FONT><FONT SIZE=2>"), by and between the Company and the Holder, the Holder has agreed to forgive any outstanding principal plus accrued but unpaid interest under the Old Notes in
consideration for (i)&nbsp;a new secured promissory note issued by the Releasors in the amount of Seven Million Eight Hundred Thousand Dollars (US $7,800,000.00), (ii)&nbsp;a
non-exclusive license to use certain proprietary technology of the Company (the "</FONT><FONT SIZE=2><I>License</I></FONT><FONT SIZE=2>") and (iii)&nbsp;this Release. </FONT></P>

<HR NOSHADE>
<P style='page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=1,EFW="2149161",CP="SEROLOGICALS CORPORATION",DN="4",CHK=634051,FOLIO='blank',FILE='DISK013:[04ATA5.04ATA1695]KJ1695A.;4',USER='SSTANSE',CD='23-DEC-2004;10:51' -->
<A NAME="page_kj1695_1_2"> </A>
<BR>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NOW,
THEREFORE, in consideration of the mutual covenants and agreements herein set forth and each act done pursuant hereto, the Purchaser Parties and the Holder Parties, intending to be
legally bound, do hereby represent, warrant, covenant and agree as follows: </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><B>ARTICLE&nbsp;I<BR>
DEFINITIONS  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.1</FONT><FONT
SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;Definitions.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Capitalized terms used and not otherwise defined herein have the meanings assigned to them in
the Stock Purchase Agreement or the Exchange Agreement (as the case may be). </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><B>ARTICLE&nbsp;II<BR>
RELEASE BY PURCHASER PARTIES  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.1</FONT><FONT
SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;Releases.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;As consideration for the transactions contemplated by this Release and the Exchange Agreement: </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;Except
as provided in the last sentence of this Section&nbsp;2.1(a), the Purchaser Parties, on behalf of themselves and their respective affiliates, subsidiaries,
parents, directors, officers, agents, principals, representatives, employees, attorneys, successors, transferees and assigns (collectively, the "</FONT><FONT SIZE=2><I>Purchaser Releasing
Parties</I></FONT><FONT SIZE=2>") hereby fully, unconditionally and completely release, acquit, discharge, and agree to hold harmless the Holder Parties, their respective affiliates, subsidiaries,
directors, officers, agents, principals, representatives</FONT><FONT SIZE=2><B>,</B></FONT><FONT SIZE=2> employees, attorneys, successors, transferees and assigns (hereinafter collectively referred
to as "</FONT><FONT SIZE=2><I>Holder Releasees</I></FONT><FONT SIZE=2>") from any and all claims, liabilities, allegations, actions, offsets or demands whatsoever which the Purchaser Parties, or any
of them, have or may have against the Holder Releasees, or any of them, whether known or unknown, suspected or unsuspected, choate or inchoate, and whenever they may have arisen from the beginning of
time until the date of the Closing with respect to any indemnification claims made or that could have been made pursuant to Section&nbsp;9.2 of the Stock Purchase Agreement or otherwise with respect
to the Acquisition. Notwithstanding the foregoing, the Purchaser Parties do not release any claim they may have against the Holder Parties with respect to the indemnification obligations of the Holder
Parties pursuant to Sections&nbsp;9.2(d) or (e)&nbsp;of the Stock Purchase Agreement. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;The
Purchaser Parties on behalf of themselves and their respective affiliates, subsidiaries, parents, directors, officers, agents, principals, representatives,
employees, attorneys, successors, transferees and assigns, hereby fully, unconditionally and completely waive and renounce their right to assert claims for indemnification pursuant to
Section&nbsp;9.2 of the Stock Purchase Agreement or otherwise with respect to the Acquisition from and after the date of the Closing, except to the extent of the reserved claims specified in the
last sentence of Section&nbsp;2.1(a). </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;The
Purchaser Parties on behalf of themselves and their respective affiliates, subsidiaries, parents, directors, officers, agents, principals, representatives,
employees, attorneys, successors, transferees and assigns, hereby fully, unconditionally and completely waive and renounce any right they may have to participate in any recovery obtained by the Holder
Parent from Cangene Corporation with respect to the Request for Equitable Adjustment referred to in Section&nbsp;5.12 of the Stock Purchase Agreement. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.2</FONT><FONT
SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;Further Assurances.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Upon the request of the Holder Releasees, the Purchaser Parties shall take such
additional actions as the Holder Releasees shall reasonably request, including the execution of documents or instruments reasonably requested by the Holder Releasees, to more fully evidence the
releases given by the Purchaser Parties pursuant to this Release. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>2</FONT></P>

<HR NOSHADE>
<P style='page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=2,EFW="2149161",CP="SEROLOGICALS CORPORATION",DN="4",CHK=914951,FOLIO='2',FILE='DISK013:[04ATA5.04ATA1695]KJ1695A.;4',USER='SSTANSE',CD='23-DEC-2004;10:51' -->
<A NAME="page_kj1695_1_3"> </A>
<BR>
<P ALIGN="CENTER"><FONT SIZE=2><B>ARTICLE&nbsp;III<BR>
RELEASE BY HOLDER PARTIES  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.1</FONT><FONT
SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;Releases.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;As consideration for the transactions contemplated by this Release and Exchange Agreement: </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;Except
as provided in the last sentence of this Section&nbsp;3.1(a), the Holder Parties, on behalf of themselves and their respective affiliates, subsidiaries,
parents, directors, officers, agents, principals, representatives, employees, attorneys, successors, transferees and assigns (collectively, the "</FONT><FONT SIZE=2><I>Holder Releasing
Parties</I></FONT><FONT SIZE=2>") hereby fully, unconditionally and completely release, acquit, discharge, and agree to hold harmless the Purchaser Parties, their respective affiliates, subsidiaries,
directors, officers, agents, principals, representatives</FONT><FONT SIZE=2><B>,</B></FONT><FONT SIZE=2> employees, attorneys, successors, transferees and assigns (hereinafter collectively referred
to as "</FONT><FONT SIZE=2><I>Purchaser Releasees</I></FONT><FONT SIZE=2>") from any and all claims, liabilities, allegations, actions, offsets or demands whatsoever which the Holder Parties, or
either of them, have or may have against the Purchaser Releasees, or any of them, whether known or unknown, suspected or unsuspected, choate or inchoate, and whenever they may have arisen from the
beginning of time until the date of the Closing with respect to any indemnification claims made or that could have been made pursuant to Section&nbsp;9.4 of the Stock Purchase Agreement or otherwise
with respect to the Acquisition. Notwithstanding the foregoing, the Holder Parties do not release any claim they may have against the Company and LG with respect to the indemnification obligations of
the Company and LG pursuant to Sections&nbsp;9.4(d), (e) or (f) of the Stock Purchase Agreement. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;The
Holder Parties on behalf of themselves and their respective affiliates, subsidiaries, parents, directors, officers, agents, principals, representatives, employees,
attorneys, successors, transferees and assigns, hereby fully, unconditionally and completely waive and renounce their right to assert claims for indemnification pursuant to Section&nbsp;9.4 of the
Stock Purchase Agreement or otherwise with respect to the Acquisition from and after the date of the Closing, except to the extent of the reserved claims specified in the last sentence of
Section&nbsp;3.1(a). </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.2</FONT><FONT
SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;Further Assurances.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Upon the request of the Purchaser Releasees, the Holder Parties shall take such
additional actions as the Purchaser Releasees shall reasonably request, including the execution of
documents or instruments reasonably requested by the Purchaser Releasees, to more fully evidence the releases given by the Holder Parties pursuant to this Release. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><B>ARTICLE&nbsp;IV<BR>
MISCELLANEOUS  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.1</FONT><FONT
SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;Notices.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;All notices, demands and other communications provided for or permitted hereunder or under this
Release shall be made in writing and shall be by registered or certified first-class mail, return receipt requested, by next day delivery through a recognized national courier or personal delivery: </FONT></P>

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE WIDTH="63%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD WIDTH="36%"><FONT SIZE=2>(a) If to the Purchaser Parties:</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="61%"><FONT SIZE=2>Life Therapeutics Limited<BR>
P.O.&nbsp;Box 6126 Frenchs Forest<BR>
22 Rodborough Road<BR>
NSW 2086, Australia<BR>
Attention: John Manusu&nbsp;&amp; Hari Nair<BR>
Telecopy: (612)&nbsp;9436-2907</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="36%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="61%"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- insert table folio -->
<BR>
<P ALIGN="CENTER"><FONT SIZE=2>3</FONT></P>

<HR NOSHADE>
<P style='page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=3,EFW="2149161",CP="SEROLOGICALS CORPORATION",DN="4",CHK=662807,FOLIO='3',FILE='DISK013:[04ATA5.04ATA1695]KJ1695A.;4',USER='SSTANSE',CD='23-DEC-2004;10:51' -->
<A NAME="page_kj1695_1_4"> </A>
<!-- end of table folio -->
<DIV ALIGN="CENTER"><TABLE WIDTH="63%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD WIDTH="36%"><FONT SIZE=2><BR>
with a copy to:</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="61%"><FONT SIZE=2><BR>
Buchanan Ingersoll PC<BR>
1776 K Street, N.W., Suite 800<BR>
Washington, DC 20006-2365<BR>
Attention: Edward John Allera, Esq.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="36%"><FONT SIZE=2><BR>
(b)&nbsp;if&nbsp;to&nbsp;the&nbsp;Holder&nbsp;Parties:&nbsp;to:</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="61%"><FONT SIZE=2><BR>
Serologicals Corporation<BR>
5655 Spalding Drive<BR>
Norcross, Georgia 30092<BR>
Attention: Vice President, General Counsel</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="36%"><FONT SIZE=2><BR>
with a copy to:</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="61%"><FONT SIZE=2><BR>
King&nbsp;&amp; Spalding LLP<BR>
191 Peachtree Street, N.E.<BR>
Atlanta, Georgia 30303-1763<BR>
Attention: G. Roth Kehoe, Esq.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
such notice, communication or delivery will be deemed given or made (a)&nbsp;on the fifth (5th) business day after it is mailed by registered or certified mail, (b)&nbsp;on the
first (1st) business day after delivery to an appropriate customer service representative if sent by next day delivery through a recognized national courier, or (c)&nbsp;on the date of delivery if
delivered in person. Any party may change its address for notice purposes by giving written notice to the other parties in the manner specified above. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.2</FONT><FONT
SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;Entire Agreement.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;This Release shall be binding upon and shall inure to the benefit of the parties hereto
and their respective successors, heirs, executors and administrators. The Releasors may execute this Release in any number of counterparts, each of which when executed and delivered, shall be an
original, but all of which when taken together shall constitute one and the same instrument. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.3</FONT><FONT
SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;Governing Law.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;This Release shall be interpreted in accordance with the laws of the State of Delaware,
without regard to any jurisdiction's conflict of law provisions. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>[</FONT><FONT
SIZE=2><I>signatures follow</I></FONT><FONT SIZE=2>] </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>4</FONT></P>

<HR NOSHADE>
<P style='page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=4,EFW="2149161",CP="SEROLOGICALS CORPORATION",DN="4",CHK=627946,FOLIO='4',FILE='DISK013:[04ATA5.04ATA1695]KJ1695A.;4',USER='SSTANSE',CD='23-DEC-2004;10:51' -->
<A NAME="page_kj1695_1_5"> </A>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN
WITNESS WHEREOF, the Purchaser Parties and the Holder Parties have duly executed this Release as of the day and year first above written. </FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2><B>PURCHASER PARTIES:</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2><BR>
LIFE THERAPEUTICS LIMITED</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=2><BR>
By:</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="50%"><FONT SIZE=2><BR>
/s/&nbsp;&nbsp;</FONT><FONT SIZE=2>JOHN MANUSU</FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2>Name: John Manusu<BR>
Title: Authorized Officer</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2><BR>
LIFE GELS,&nbsp;INC.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=2><BR>
By:</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="50%"><FONT SIZE=2><BR>
/s/&nbsp;&nbsp;</FONT><FONT SIZE=2>JOHN MANUSU</FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2>Name: John Manusu<BR>
Title: Authorized Officer</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2><BR>
LIFE THERAPEUTICS PLASMA HOLDINGS,&nbsp;INC.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=2><BR>
By:</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="50%"><FONT SIZE=2><BR>
/s/&nbsp;&nbsp;</FONT><FONT SIZE=2>JOHN MANUSU</FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2>Name: John Manusu<BR>
Title: Authorized Officer</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2><BR>
LIFESERA,&nbsp;INC.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=2><BR>
By:</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="50%"><FONT SIZE=2><BR>
/s/&nbsp;&nbsp;</FONT><FONT SIZE=2>JOHN MANUSU</FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2>Name: John Manusu<BR>
Title: Authorized Officer</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2><BR>
LIFESERA NEVADA,&nbsp;INC.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=2><BR>
By:</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="50%"><FONT SIZE=2><BR>
/s/&nbsp;&nbsp;</FONT><FONT SIZE=2>JOHN MANUSU</FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2>Name: John Manusu<BR>
Title: Authorized Officer</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2><BR>
LIFESERA BUSINESS TRUST</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=2><BR>
By:</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="50%"><FONT SIZE=2><BR>
/s/&nbsp;&nbsp;</FONT><FONT SIZE=2>JOHN MANUSU</FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2>Name: John Manusu<BR>
Title: Authorized Officer</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2><BR>
LIFESERA INVESTMENTS, LLC</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=2><BR>
By:</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="50%"><FONT SIZE=2><BR>
/s/&nbsp;&nbsp;</FONT><FONT SIZE=2>JOHN MANUSU</FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2>Name: John Manusu<BR>
Title: Authorized Officer</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2><BR>
LIFESERA MANAGEMENT PARTNERSHIP, LP</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=2><BR>
By:</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="50%"><FONT SIZE=2><BR>
/s/&nbsp;&nbsp;</FONT><FONT SIZE=2>JOHN MANUSU</FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2>Name: John Manusu<BR>
Title: Authorized Officer</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="50%"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE>
<!-- insert table folio -->
<BR>
<P ALIGN="CENTER"><FONT SIZE=2>5</FONT></P>

<HR NOSHADE>
<P style='page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=5,EFW="2149161",CP="SEROLOGICALS CORPORATION",DN="4",CHK=142801,FOLIO='5',FILE='DISK013:[04ATA5.04ATA1695]KJ1695A.;4',USER='SSTANSE',CD='23-DEC-2004;10:51' -->
<A NAME="page_kj1695_1_6"> </A>
<!-- end of table folio -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2><BR>
ALLEGHENY BIOLOGICALS,&nbsp;INC.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=2><BR>
By:</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="50%"><FONT SIZE=2><BR>
/s/&nbsp;&nbsp;</FONT><FONT SIZE=2>JOHN MANUSU</FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2>Name: John Manusu<BR>
Title: Authorized Officer</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3><BR><FONT SIZE=2><B>HOLDER PARTIES:</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2><BR>
SEROLOGICALS CORPORATION</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=2><BR>
By:</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="50%"><FONT SIZE=2><BR>
/s/&nbsp;&nbsp;</FONT><FONT SIZE=2>HAROLD W. INGALLS</FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2>Name: Harold W. Ingalls<BR>
Title: Vice President, Finance and Chief Financial Officer</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2><BR>
SEROLOGICALS FINANCE COMPANY</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=2><BR>
By:</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="50%"><FONT SIZE=2><BR>
/s/&nbsp;&nbsp;</FONT><FONT SIZE=2>HAROLD W. INGALLS</FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2>Name: Harold W. Ingalls<BR>
Title: President</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<P ALIGN="CENTER"><FONT SIZE=2>6</FONT></P>

<HR NOSHADE>
<P style='page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=6,EFW="2149161",CP="SEROLOGICALS CORPORATION",DN="4",CHK=381940,FOLIO='6',FILE='DISK013:[04ATA5.04ATA1695]KJ1695A.;4',USER='SSTANSE',CD='23-DEC-2004;10:51' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<BR>
<P><br><A NAME="04ATA1695_4">QuickLinks</A><br></P><!-- TOC_BEGIN -->
<UL>
<FONT SIZE=2><A HREF="#toc_kj1695_1">Exhibit 1.3</A></FONT><BR>
</UL>
<FONT SIZE=2><A HREF="#toc_kj1695_2">MUTUAL RELEASE AGREEMENT</A></FONT><BR>
<!-- SEQ=,FILE='QUICKLINK',USER=SSTANSE,SEQ=,EFW="2149161",CP="SEROLOGICALS CORPORATION",DN="4" -->
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>

